Clinical Trial Update: Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of bendamustine hydrochloride in patients with relapsed or refractory malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Bendamustine Hydrochloride (bendamustine)

Snippet

Sponsor: Cephalon | Conditions: Malignancy | Phase 1 | Status: COMPLETED